Eli Lilly & Co. (LLY)
1046.00
-12.56
(-1.19%)
USD |
NYSE |
Feb 24, 13:20
Eli Lilly Market Cap : 986.75B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 205.37B |
| Biogen, Inc. | 28.86B |
| Regeneron Pharmaceuticals, Inc. | 82.21B |
| Viking Therapeutics, Inc. | 3.913B |
| Moderna, Inc. | 19.97B |
Market Cap Related Metrics
| PE Ratio | 46.30 |
| PS Ratio | 14.62 |
| PEG Ratio | 0.4792 |
| Price to Book Value | 37.19 |
| Price to Free Cash Flow | 159.78 |
| Price | 1046.00 |
| Earnings Yield | 2.16% |
| PEGY Ratio | 0.4764 |
| Operating PE Ratio | 32.09 |
| Normalized PE Ratio | 42.16 |